MitoKor, a biotech company developing drugs to treat Alzheimer's disease (in Phase III clinical trials), Parkinson's disease (in Phase I) and other drugs to treat neurological, metabolic and degenerative diseases, filed an S-1 Friday. The San Diego, CA based company has selected RBC Capital Markets to lead manage this deal.
IPO Pro - "The Ultimate Resource for IPOs"
Don't risk buying another IPO without IPO Pro.
Get your FREE TRIAL now.
